Loss of p53 cooperates with K-ras activation to induce glioma formation in a region-independent manner

GLIA

Volumn 61, Issue 11, 2013, Pages 1862-1872

  Muñoz, Diana Marcela ^a   Tung, Takyee ^a   Agnihotri, Sameer ^a   Singh, Sanjay ^a   Guha, Abhijit ^a,b   Zadeh, Gelareh ^a,b   Hawkins, Cynthia ^a,c  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Gliomagenesis; Inducible expression system; K ras; Mouse model; Region of origin

Indexed keywords

DOXYCYCLINE; K RAS PROTEIN; PROTEIN P53;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL POPULATION; CELL TYPE; CONTROLLED STUDY; GENE MUTATION; GLIOMA; MOUSE; MUTATION; NEURAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REMISSION; STEM CELL; SUBVENTRICULAR ZONE; TUMOR REGRESSION;

GLIOMAGENESIS; INDUCIBLE EXPRESSION SYSTEM; K-RAS; MOUSE MODEL; REGION OF ORIGIN;

ANIMALS; BRAIN; BRAIN NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; GENES, RAS; GLIOMA; MICE; MICE, TRANSGENIC; MUTATION; STEM CELLS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84884725584     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22563     Document Type: Article

References (41)

1. Alcantara Llaguno S, Chen J, Kwon C, Jackson E, Li Y, Burns D, Alvarez Buylla A, Parada L. 2009. Malignant Astrocytomas Originate from Neural Stem/Progenitor Cells in a Somatic Tumor Suppressor Mouse Model. Cancer Cell 15:45-56.
2. Assanah M, Lochhead R, Ogden A, Bruce J, Goldman J, Canoll P. 2006. Glial progenitors in adult white matter are driven to form malignant gliomas by platelet-derived growth factor-expressing retroviruses. J Neurosci 26:6781-6790.
3. Belteki G, Haigh J, Kabacs N, Haigh K, Sison K, Costantini F, Whitsett J, Quaggin SE, Nagy A. 2005. Conditional and inducible transgene expression in mice through the combinatorial use of Cre-mediated recombination and tetracycline induction. Nucleic Acids Res 33:e51.
4. Bohman L-E, Swanson KR, Moore JL, Rockne R, Mandigo C, Hankinson T, Assanah M, Canoll P, Bruce JN. 2010a. Magnetic resonance imaging characteristics of glioblastoma multiforme: Implications for understanding glioma ontogeny. Neurosurgery 67:1319-1327; discussion 1327-1328.
5. Cahill DP, Lengauer C, Yu J, Riggins GJ, Willson JK, Markowitz SD, Kinzler KW, Vogelstein B. 1998. Mutations of mitotic checkpoint genes in human cancers. Nature 392:300-303.
6. Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, Antipin Y, Reva B, Goldberg AP, Sander C, Schultz N. 2012. The cBio cancer genomics portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov 2:401-404.
7. Chin L, Tam A, Pomerantz J, Wong M, Holash J, Bardeesy N, Shen Q, O'Hagan R, Pantginis J, Zhou H, Horner, JW, 2nd Cordon-Cardo, C. Yancopoulos, G. 1999. Essential role for oncogenic Ras in tumour maintenance. Nature 400:468-472.
8. Cutts BA, Sjogren AK, Andersson KM, Wahlstrom AM, Karlsson C, Swolin B, Bergo MO. 2009. Nf1 deficiency cooperates with oncogenic K-RAS to induce acute myeloid leukemia in mice. Blood 114:3629-3632.
9. Doetsch F, Alvarez-Buylla A. 1996. Network of tangential pathways for neuronal migration in adult mammalian brain. Proc Natl Acad Sci USA 93:14895-14900.
10. Doetsch F, Caillé I, Lim DA, García-Verdugo JM, Alvarez-Buylla A. 1999. Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell 97:703-716.
11. Eriksson PS, Perfilieva E, Bjork-Eriksson T, Alborn AM, Nordborg C, Peterson DA, Gage FH. 1998. Neurogenesis in the adult human hippocampus. Nat Med 4:1313-1317.
12. Feldkamp MM, Lau N, Guha A. 1999. The farnesyltransferase inhibitor L-744, 832 inhibits the growth of astrocytomas through a combination of antiproliferative, antiangiogenic, and proapoptotic activities. Ann N Y Acad Sci 886:257-260.
13. Fisher GH, Wellen SL, Klimstra D, Lenczowski JM, Tichelaar JW, Lizak MJ, Whitsett JA, Koretsky A, Varmus HE. 2001. Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes. Genes Dev 15:3249-3262.
14. Friedmann-Morvinski D, Bushong EA, Ke E, Soda Y, Marumoto T, Singer O, Ellisman MH, Verma IM. Dedifferentiation of neurons and astrocytes by oncogenes can induce gliomas in mice. Science 338 (6110):1080-1084.
15. Gage FH. 2000. Mammalian neural stem cells. Science 287:1433-1438.
16. Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al. 2013. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 6:pl1.
17. Gensert JM, Goldman JE. 2001. Heterogeneity of cycling glial progenitors in the adult mammalian cortex and white matter. J Neurobiol 48:75-86.
18. Hambardzumyan D, Cheng YK, Haeno H, Holland EC, Michor F. 2011. The probable cell of origin of NF1- and PDGF-driven glioblastomas. PLoS ONE 6:e24454.
19. Hanahan D, Weinberg Robert A. 2011. Hallmarks of Cancer: The Next Generation. Cell 144:646-674.
20. Hegedus B, Dasgupta B, Shin JE, Emnett RJ, Hart-Mahon EK, Elghazi L, Bernal-Mizrachi E, Gutmann DH. 2007. Neurofibromatosis-1 regulates neuronal and glial cell differentiation from neuroglial progenitors in vivo by both cAMP- and Ras-dependent mechanisms. Cell Stem Cell 1:443-457.
21. Holland EC, Celestino J, Dai C, Schaefer L, Sawaya RE, Fuller GN. 2000. Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nat Genet 25:55-57.
22. Jonkers J, Meuwissen R, van der Gulden H, Peterse H, van der Valk M, Berns A. 2001. Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. Nat Genet 29:418-425.
23. Kleihues P, Soylemezoglu F, Schauble B, Scheithauer BW, Burger PC. 1995. Histopathology, classification, and grading of gliomas. Glia 15:211-221.
24. Kohl NE, Wilson FR, Thomas TJ, Bock RL, Mosser SD, Oliff A, Gibbs JB. 1995. Inhibition of Ras function in vitro and in vivo using inhibitors of farnesyl-protein transferase. Methods Enzymol 255:378-386.
25. Lengauer C, Kinzler KW, Vogelstein B. 1998. Genetic instabilities in human cancers. Nature 396:643-649.
26. Lim DA, Cha S, Mayo MC, Chen M-H, Keles E, VandenBerg S, Berger MS. 2007a. Relationship of glioblastoma multiforme to neural stem cell regions predicts invasive and multifocal tumor phenotype. Neuro Oncol 9:424-429.
27. Lim LP, Tay FB, Sum CF, Thai AC. 2007b. Relationship between markers of metabolic control and inflammation on severity of periodontal disease in patients with diabetes mellitus. J Clin Periodontol 34:118-123.
28. Liu C, Sage Jonathan C, Miller Michael R, Verhaak Roel GW, Hippenmeyer S, Vogel H, Foreman O, Bronson Roderick T, Nishiyama A, Luo L, Zong, Hui. 2011. Mosaic analysis with double markers reveals tumor cell of origin in glioma. Cell 146:209-221.
29. Lobell RB, Omer CA, Abrams MT, Bhimnathwala HG, Brucker MJ, Buser CA, Davide JP, deSolms SJ, Dinsmore CJ, Ellis-Hutchings MS, Kral AM, Liu D, Lumma WC, Machotka SV, Rands E, Williams TM, Graham SL, Hartman GD, Oliff AI, Heimbrook DC, Kohl NE. 2001. Evaluation of farnesyl:protein transferase and geranylgeranyl: Protein transferase inhibitor combinations in preclinical models. Cancer Res 61:8758-8768.
30. Luo J, Deng ZL, Luo X, Tang N, Song WX, Chen J, Sharff KA, Luu HH, Haydon RC, Kinzler KW, Vogelstein B, He TC. 2007. A protocol for rapid generation of recombinant adenoviruses using the AdEasy system. Nature Protoc 2:1236-1247.
31. Sanai N, Alvarez-Buylla A, Berger MS. 2005. Neural stem cells and the origin of gliomas. N Engl J Med 353:811-822.
32. Sanai N, Tramontin AD, Quinones-Hinojosa A, Barbaro NM, Gupta N, Kunwar S, Lawton MT, McDermott MW, Parsa AT, Manuel-Garcia Verdugo J, et al. 2004. Unique astrocyte ribbon in adult human brain contains neural stem cells but lacks chain migration. Nature 427:740-744.
33. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, Dirks PB. 2003. Identification of a cancer stem cell in human brain tumors. Cancer Res 63:5821-5828.
34. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB. 2004. Identification of human brain tumour initiating cells. Nature 432:396-401.
35. TCGA. 2008. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455:1061-1068.
36. Uhrbom L, Dai C, Celestino JC, Rosenblum MK, Fuller GN, Holland EC. 2002. Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt. Cancer Research 62:5551-5558.
37. Venere M, Fine HA, Dirks PB, Rich JN. 2011. Cancer stem cells in gliomas: Identifying and understanding the apex cell in cancer's hierarchy. Glia 59:1148-1154.
38. Vintersten K, Monetti C, Gertsenstein M, Zhang P, Laszlo L, Biechele S, Nagy A. 2004. Mouse in red: red fluorescent protein expression in mouse ES cells, embryos, and adult animals. Genesis 40:241-246.
39. von Deimling A, Louis DN, Wiestler OD. 1995. Molecular pathways in the formation of gliomas. Glia 15:328-338.
40. Yeh TH, Lee da Y, Gianino SM, Gutmann DH. 2009. Microarray analyses reveal regional astrocyte heterogeneity with implications for neurofibromatosis type 1 (NF1)-regulated glial proliferation. Glia 57:1239-1249.
41. Zhu Y, Guignard F, Zhao D, Liu L, Burns DK, Mason RP, Messing A, Parada LF. 2005. Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma. Cancer Cell 8:119-130.